The Insider: Meet the CEOs – 5th April

MedAdvisor provides simple medication communication solutions to improve patients’ awareness and understanding of their medications. The company’s mobile app, pharmacy software and patient engagement solutions encompass a comprehensive medication adherence platform addressing a US$600 billion problem. In H1 FY23, MedAdvisor earned $64.1 million and posted a record positive EBITDA of $8.6 million (up $13.1 million on H1 FY22). Operating within a total addressable market of US$16 billion (as at March 2023), the company aims to leverage its digital capabilities and accelerate expansion further into the global market.

Site specialises in providing Australian-standard skilled labour training courses to the workforces of global companies within the resources, construction, hospitality and industrial sectors. The company partners with the likes of ExxonMobil, Saudi Aramco, GE and Oceana Gold. Before being sidelined by COVID, Site grew at a 63.84% compound annual growth rate (CAGR) for nine years to record almost $31 million revenue in FY19. The company is pursuing a robust recovery plan, and owns 38.4% of a 30-hectare commercial leasehold in a thriving city in the Philippines.

VHM has one of the largest high-grade battery mineral and rare earth projects on the planet and aims to build one of the world’s largest critical minerals projects. The company’s flagship Goschen project, has been described as a superior resource in scale, grade and processability, and has been granted “Major Project Status” by the Australian Government. VHM’s 629Mt of mineral resource inventory positions VHM as one of the most significant producers of rare earth minerals globally. In a recently released Definitive Feasibility Study Refresh, the Goschen project was confirmed to hold robust economics and a net present value of approximately $1.5 billion.